Hinge Bio

Hinge Bio specializes in leveraging its proprietary Flex-Hinge antibody platform to develop bispecific and multispecific antibodies.

Overview Structured Data Issues Contributors

Is a

Company attributes

Industry

Biomedical engineering

Pharmaceutical industry

Health technology

Location

Burlingame, California

CEO

Founder

Pitchbook URL

pitchbook.com/profiles...222425-65

Number of Employees (Ranges)

11 – 50

Email Address

info@hingebio.com

Investors

InVivium Capital

Lightswitch Capital

Baruch Future Ventures

0

Total Funding Amount (USD)

30,000,000

Latest Funding Round Date

January 15, 2025

Latest Funding Type

Country

Other attributes

Company Operating Status

Active

Latest Funding Round Amount (USD)

30,000,000

No article content yet.

Timeline

No Timeline data yet.

Funding Rounds

Products

Acquisitions

SBIR/STTR Awards

Patents

Further Resources

Title

Author

Link

Type

Date

No Further Resources data yet.

References

Find more companies like Hinge Bio

Use the Golden Query Tool to find similar companies in the same industry, location, or by any other field in the Knowledge Graph.

Open Query Tool

Golden Query Tool

By using this site, you agree to our Terms of Service.